Article Details
Retrieved on: 2024-10-16 18:32:20
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses FDA approval of gene therapies for sickle cell disease, highlighting their slow adoption due to a smaller target market and existing alternatives. This relates to 'regenerative medicine' through gene therapy and stem cell applications.
Article found on: www.ajmc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here